As we will probably never have a direct randomized comparison, we have to rely on these inderect comparinos of CV effects of semaglutide and tirzepatide This study combined oral and injectable semaglutide and the comparison with tirzepatide showed no differences in CV outcomes At the same time the efficacy in decreasing body weight and improving metabolic parameters is significantly better for tirzeptide What we dont know yet are CV data for tirzepatide in non-diabetics
Two years later, in 1932, La Barre coined the term 'incrtine' (incretin) for a substance he extracted from the upper gut mucosa that lowered blood glucose when injected into normal rabbits and dogs
For each outcome, we combined results from multiple GWAS using both fixed-effects and random-effects models
Lee J, Hong SW, Kim MJ, Kwon H, Park SE, Rhee EJ, et al
Rybelsus (semaglutide) tablets [product information]
doi: 10.1002/iub.1646